with this Order, which validates Oxford BioMedica's patents and
strengthens our position in this field." Oxford BioMedica's LentiVector
system has broad applications in gene delivery and can be used to deliver
shRNA-encoding DNA to cells to enable RNA Interference (RNAi) experiments.
Based on discoveries by Oxford Biomedica's Drs. Susan and Alan Kingsman and
others, scientists are now able to safely use modified lentiviruses as
vectors, which enable RNAi to be effectively utilized as a research tool to
unlock the secrets of the genetic code. As stated in the Court's Order, the
viral vector developed by the Kingsmans' is expected to be useful as a
"smart bomb" to safely "deliver new genetic material into specific cells,
such as cells that do not divide or that divide slowly," giving the
delivery of genes that produce dopamine into a Parkinson's disease
patient's brain cells, as an example.
"Sigma believes this technology holds huge promise to better understand
the human genome and to, ultimately, help devise techniques to defeat and
diminish longstanding misery-causing diseases such as Parkinson's and
Alzheimer's," said Smoller.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High
Technology company. Its biochemical and organic chemical products and kits
are used in scientific and genomic research, biotechnology, pharmaceutical
development, the diagnosis of disease and as key components in
pharmaceutical and other high technology manufacturing. The Company has
customers in life science companies, university and government
institutions, hospitals, and in industry. Over one million scientists and
technologists use its products. Sigma-Aldrich operates in 36 countries and
has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is
committed to Accelerating Customer Success through Leadership in Life
Science, High Technology and Service. For more information about
Sigma-Aldrich, please visit its award-winning Web site at
'/>"/>
SOURCE Sigma-Aldrich Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Biomedical engineering conference invites manufacturers2.
Manufacturing partnership will move into biotech and biomedical spaces3.
Biomedical Alliance about more than stem cells4.
Doyle seeks $2.5M for biomedical alliance5.
Students will show off biomedical devices to professors and investors6.
Biomedical alliance marks first full year7.
UW Biomedical Engineering awarded $2.9 million research grant8.
Having two biomedical tech centers in Wisconsin will help the state9.
New biomedical institute aims to unite business and academia in SE Wisconsin10.
Wisconsin publicly traded biomedical companies report gains this quarter11.
IRS ruling could speed healthcare technology adoption